TY - BOOK AU - Carlos,Celia C. AU - Inobaya,Marianette T. AU - Bresee,Joseph S. AU - Lagrada,Marietta L. AU - Olorosa,Agnettah M. AU - Kirkwood,Carl D. AU - Widdowson,Marc-Alain TI - The burden of hospitalizations and clinic visits for rotavirus disease in children aged <5 years in the Philippines KW - Child, Preschool KW - Cost of Illness KW - Gastroenteritis KW - epidemiology KW - Rotavirus KW - classification KW - Rotavirus Infections KW - virology N2 - Background: Recent data on the burden of hospitalization and clinic visits for rotavirus gastroenteritis are needed to support the decision to introduce rotavirus vaccine in the Philippines. Methods: From 2005 through 2006, children aged <5 years with acute diarrhea who attended 1 of 7 clinics and/or hospitals in Muntinlupa City, the Philippines, were enrolled. Clinical and demographic data were collected, and a stool specimen was obtained for rotavirus testing and typing for G and P antigens. The incidences of different clinical outcomes of rotavirus gastroenteritis were determined for 3 townships under surveillance and were extrapolated to the Philippines with use of national data sets. Results: The prevalence of rotavirus was 31% (171/560) among children hospitalized with diarrhea, 30% (155/520) among those who presented to the emergency department, and 15% (56/385) among those who presented to a clinic. The annual estimated incidence (per 100,000 children aged <5 years) of rotavirus gastroenteritis in outpatient, emergency department, and inpatient settings was 755, 451, and 279, respectively. Of 274 strains, 50 (18%) were nontypeable. Of the 128 strains that underwent G and P typing, 98% belong to the globally common strains G3P[P], G2P[4], and G1P[8]. Conclusions: The burden of rotavirus gastroenteritis in the Philippines is high and is predominantly caused by strains against which current vaccines have shown good efficacy, suggesting that routine immunization will have a large impact on rotavirus disease burden UR - https://academic.oup.com/jid/article/200/Supplement_1/S174/848665 ER -